Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun;49(6):1315-1317.
doi: 10.1161/STROKEAHA.118.021262. Epub 2018 May 8.

Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem

M Edip Gurol  1
Affiliations
Editorial

Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem

M Edip Gurol. Stroke. 2018 Jun.
No abstract available

Keywords: Editorials; anticoagulants; atrial appendage; atrial fibrillation; secondary prevention; stroke.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European Heart Journal. 2018 (in press) - PubMed
    1. Gurol ME. Nonpharmacological management of atrial fibrillation in patients at high intracranial hemorrhage risk. Stroke. 2018;49:247–254. - PMC - PubMed
    1. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet. 2009;374:534–542. - PubMed
    1. Holmes DR, Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. Journal of the American College of Cardiology. 2014;64:1–12. - PubMed
    1. Reddy VY, Akehurst RL, Amorosi SL, Gavaghan MB, Hertz DS, Holmes DR. Cost effectiveness of left atrial appendage closure with the Watchman device compared to warfarin or NOACs for secondary prevention in NVAF. Stroke. 2018 (in press) - PMC - PubMed

Publication types

MeSH terms